Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
SUSPENDED
320 participants
OBSERVATIONAL
2019-03-19
2020-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Performance of Ellume·Lab Group A Strep Test Versus Culture for the Rapid Detection of Group A Streptococcus in Participants With Acute Pharyngitis
NCT03693495
A Study of MK-3009 in Japanese Patients With Skin or Blood Stream Infections Caused by Methicillin-resistant Staphylococcus Aureus (MK-3009-002)
NCT00770341
Dräger COVID-19 Antigen Test Clinical Performance Study
NCT04698993
Controlled Human Infection for Vaccination Against Streptococcus Pyogenes
NCT03361163
Performance of Ellume·Lab Group A Strep Test Versus Culture for the Rapid Detection of Group A Streptococcus in Patients With Acute Pharyngitis.
NCT03171350
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Symptoms of Strep Throat
Any patient presenting with symptoms of pharyngitis
* Fever
* Sore throat
* Swollen lymph nodes in neck
* Redness of throat/tonsils
* White/yellow patches on tonsils
* Not currently on antibiotics
Preview Rapid Strep A test
Rapid assay for the detection of type A streptococcal infection of the throat.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Preview Rapid Strep A test
Rapid assay for the detection of type A streptococcal infection of the throat.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Fever
* Sore throat
* Swollen lymph nodes in neck
* Redness of throat/tonsils
* White/yellow patches on tonsils
* Not currently on antibiotics
* ≥3 years or older
* Ability to read, understand and sign a consent form, in English, or for parent(s) to sign an assent form providing permission to include children under the age of 18.
Exclusion Criteria
* Previously enrolled in this study
3 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Guangzhou Wondfo Biotech Co., Ltd
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Paul Granato, PhD
Role: PRINCIPAL_INVESTIGATOR
UHSH Microbiology
Jagmohan Sidhu, MD
Role: PRINCIPAL_INVESTIGATOR
UHSH Microbiology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UHSH Microbiology
Johnson City, New York, United States
Summerwood Pediatrics
Liverpool, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MDC_2018_Wondfo
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.